Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-15-007780
Filing Date
2015-11-09
Accepted
2015-11-09 16:08:42
Documents
1
Period of Report
2015-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4139
  Complete submission text file 0000899243-15-007780.txt   5655
Mailing Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102 (206) 504-7278
TAPIMMUNE INC (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4275 EXECUTIVE SQUARE SUITE 230 LA JOLLA CA 92037
Business Address
BONFIGLIO JOHN N (Reporting) CIK: 0001222253 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27239 | Film No.: 151215662